In short
The 2025 China migraine patient guide explains recognizing migraine (pulsating, one-sided, with nausea/light sensitivity), trigger management, acute abortive treatment, and preventive therapy including new CGRP-targeted options.
What this guide covers: Recognizing migraine · Trigger and lifestyle management · Acute treatment · Prevention · For patients
Recognizing migraine
Migraine is a recurrent neurological headache—typically throbbing, often one-sided, lasting 4–72 hours, and worsened by activity with nausea and sensitivity to light or sound. Some people have aura (visual or sensory warning signs).
Trigger and lifestyle management
Common triggers include irregular sleep, skipped meals, stress, certain foods, and dehydration. Keeping a headache diary helps identify and reduce personal triggers; regular routines and exercise help.
Acute treatment
Mild attacks may respond to simple analgesics; moderate-to-severe attacks use triptans or gepants. Treatment works best taken early, and overuse (rebound) must be avoided.
Prevention
Frequent or disabling migraine warrants preventive therapy—older agents (beta-blockers, topiramate, antidepressants) and newer CGRP monoclonal antibodies or oral CGRP antagonists are now available in China.
For patients
If headaches are frequent or suddenly 'the worst ever,' or come with weakness or speech trouble, get urgent evaluation to rule out other causes.
Sources and further reading
One reference to a U.S. government health source (National Institutes of Health or MedlinePlus) for the medical background of this guide. It is context, not a substitute for advice from your treating doctor.
General information for international patients, not medical advice or a diagnosis. Read the medical disclaimer.





